Cholecystitis in a preterm infant.
Bunyapen
C
C
Howell
C G
CG
Kanto
W P
WP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000150:complications / Q000628:therapy; D002764:Cholecystitis / Q000150:complications / Q000209:etiology* / Q000628:therapy; D002769:Cholelithiasis / Q000150:complications / Q000209:etiology* / Q000628:therapy; D003937:Diagnosis, Differential; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis; D005665:Furosemide / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D008297:Male; D010288:Parenteral Nutrition / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D005665:Furosemide